Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M HORWITZ

Showing results (31-40 of 828) with videos related to

Pageof 83
Sort By:
Current Hematologic Malignancy Reports|November 17, 2010
The emerging role of histone deacetylase inhibitors in treating T-cell lymphomasSteven M Horwitz
Cytotherapy|March 21, 2009
Culture conditions shape mesenchymal stromal cell phenotype and functionEdwin M Horwitz
Nature Reviews. Urology|October 7, 2009
Prostate cancer: Optimizing the duration of androgen deprivation therapyEric M Horwitz
The Maryland Nurse|January 1, 1991
The nursing shortage: problem or challenge?D M Horwitz
Clinical Advances in Hematology & Oncology : H&O|April 10, 2015
Highlights in T-cell lymphoma From the 2013 American Society of Hematology Annual Meeting and Exposition: commentarySteven M Horwitz
Brachytherapy|January 24, 2012
ABS brachytherapy consensus guidelinesEric M Horwitz,
American Journal of Psychoanalysis|September 1, 1994
A Horneyan analytic perspective on couple therapy: a case studyN M Horwitz
Cytotherapy|April 16, 2002
Marrow mesenchymal cell transplantation for genetic disorders of boneE M Horwitz
Cytotherapy|January 19, 2008
Mesenchymal stromal cells moving forwardE M Horwitz
Clinical Advances in Hematology & Oncology : H&O|June 19, 2012
Romidepsin for previously treated patients with peripheral or aggressive T-cell lymphomasSteven M Horwitz
Pageof 83

Showing results (31-40 of 828) with videos related to

Sort By:
Pageof 83
Current Hematologic Malignancy Reports|November 17, 2010
The emerging role of histone deacetylase inhibitors in treating T-cell lymphomasSteven M Horwitz
Cytotherapy|March 21, 2009
Culture conditions shape mesenchymal stromal cell phenotype and functionEdwin M Horwitz
Nature Reviews. Urology|October 7, 2009
Prostate cancer: Optimizing the duration of androgen deprivation therapyEric M Horwitz
The Maryland Nurse|January 1, 1991
The nursing shortage: problem or challenge?D M Horwitz
Clinical Advances in Hematology & Oncology : H&O|April 10, 2015
Highlights in T-cell lymphoma From the 2013 American Society of Hematology Annual Meeting and Exposition: commentarySteven M Horwitz
Brachytherapy|January 24, 2012
ABS brachytherapy consensus guidelinesEric M Horwitz,
American Journal of Psychoanalysis|September 1, 1994
A Horneyan analytic perspective on couple therapy: a case studyN M Horwitz
Cytotherapy|April 16, 2002
Marrow mesenchymal cell transplantation for genetic disorders of boneE M Horwitz
Cytotherapy|January 19, 2008
Mesenchymal stromal cells moving forwardE M Horwitz
Clinical Advances in Hematology & Oncology : H&O|June 19, 2012
Romidepsin for previously treated patients with peripheral or aggressive T-cell lymphomasSteven M Horwitz
Pageof 83